Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-03-19 @ 1:28 PM
Study NCT ID:
NCT01679860
Status:
COMPLETED
Last Update Posted:
2012-09-06
First Post:
2012-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PTCL-062006-004234-33
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None